Alzheimer's disease: Current therapy with cholinesterase inhibitors - Is it enzyme inhibition only?

被引：0

作者：

Enz, A ^{[1
]}

机构：

[1] Novartis Pharma AG, Res Nervous Syst, Basel, Switzerland

来源：

INTERNATIONAL PSYCHOGERIATRICS | 2003年 / 15卷

关键词：

D O I：

暂无

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

引用

页码：178 / 178

页数：1

共 50 条

[21] A review on cholinesterase inhibitors for Alzheimer’s disease
Preet Anand
Baldev Singh
Archives of Pharmacal Research, 2013, 36 : 375 - 399
[22] Cholinesterase inhibitors: beyond Alzheimer's disease
Larner, A. J.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (11) : 1699 - 1705
[23] Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications
Giacobini, E
NEUROCHEMISTRY INTERNATIONAL, 1998, 32 (5-6) : 413 - 419
[24] Therapy control of Alzheimer's disease with cholinesterase inhibitors using PET.
Graichen, S
Risse, JH
Sengupta, S
Kratzsch, T
Menzel, C
Frölich, L
Grünwald, F
JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 224P - 224P
[25] Cholinesterase inhibitors for Alzheimer disease
Finucane, TE
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (18): : 2359 - 2359
[26] Cholinesterase inhibitors affect disease progression in Alzheimer's disease
Marini, S.
Bessi, V.
Padiglioni, S.
Nacmias, B.
Bagnoli, S.
Sorbi, S.
Bracco, L.
JOURNAL OF NEUROLOGY, 2013, 260 : S165 - S165
[27] Switching cholinesterase inhibitors in patients with Alzheimer's disease
Emre, M
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 64 - 72
[28] Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease
Jönsson, L
PHARMACOECONOMICS, 2003, 21 (14) : 1025 - 1037
[29] Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review
Brady, Roseanna
Weinman, John
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (5-6) : 351 - 363
[30] Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer’s disease
Linus Jönsson
PharmacoEconomics, 2003, 21 : 1025 - 1037

← 1 2 3 4 5 →